Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ann Vasc Surg. 2023 Aug 14;97:163–173. doi: 10.1016/j.avsg.2023.07.102

Table II.

Operative details and device characteristics

Total (N=184) CKD 1–2 (N=107) CKD 3–5 (N=77) P value
Number of target vessels 2.8 ± 0.5 2.9 ± 0.5 2.8 ± 0.5 .03
Device type .04
 Cook ZFEN 177 (96.2) 100 (93.5) 77 (100)
 Cook P-Branch 7 (3.8) 7 (6.54) 0 (0)
Device diameter, mm 30.4 ± 3.4 30.2 ± 3.4 30.6 ± 3.4 .44
Percutaneous access only 86 (46.7) 56 (52.3) 30 (39.0) .07
Brachial or axillary access 8 (4.4) 7 (6.5) 1 (1.3) .14
Right renal artery stent diameter, mm 6.3 ± 0.5 6.3 ± 0.5 6.1 ± 0.6 .03
Left renal artery stent diameter, mm 6.4 ± 0.6 6.4 ± 0.6 6.2 ± 0.6 .03
Estimated blood loss, mL 275 ± 285 228 ± 239 342 ± 330 .01
Median fluoroscopy time (IQR), min 52.1 (34.0) 50.9 (33.1) 56.7 (32.9) .19
Median radiation dose (IQR), mGy 3558 (3396) 3312 (3318) 3742 (3616) .17
Contrast volume, mL 94 ± 40 95 ± 42 93 ± 38 .64
Operating room time, min 172 ± 77 162 ± 71 186 ± 83 .04
Technical successa 179 (97.3) 106 (99.1) 73 (94.8) .16
Median length of stay (IQR), days 2 (2) 2 (2) 3 (2) <.01

Values reported as number (%) or mean ± standard deviation, unless otherwise indicated.

CKD, chronic kidney disease; IQR, interquartile range.

a

Technical success defined as all target vessels patent without proximal endoleak on completion angiogram.